feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Gold prices reach record highs

trending

Juventus takeover bid rejected

trending

Mbappé scores, Madrid beats Alaves

trending

Dhurandhar beats Hindi film records

trending

Bangalore cold wave continues

trending

Railways plans for pay commission

trending

India vs South Africa live

trending

Heavy rain alert issued

trending

Snapchat woos Indian advertisers

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Long Covid Tied to Chronic Inflammation

Long Covid Tied to Chronic Inflammation

15 Dec

•

Summary

  • New research links chronic inflammation to persistent long covid symptoms.
  • Study found activated immune defenses and heightened inflammation over six months.
  • Findings could pave way for new anti-inflammatory treatments for long covid.
Long Covid Tied to Chronic Inflammation

Recent scientific investigations indicate that persistent inflammation might be the underlying cause of long-lasting symptoms associated with COVID-19. Research published in Nature Immunology reveals that individuals experiencing long covid maintained activated immune defenses and heightened inflammatory responses for more than six months after their initial infection.

This discovery is significant for the estimated over 400 million individuals globally affected by long covid, a condition for which no specific drugs are currently approved. The study's lead author suggests these findings point towards potential therapeutic targets related to inflammation, which warrant further clinical exploration.

While the study involved a limited number of participants, the observed patterns suggest that targeting inflammation could be a key strategy in developing effective treatments for long covid, offering hope for millions seeking relief from a wide range of debilitating symptoms.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The study found that people with long covid had activated immune defenses and heightened inflammatory responses for over six months after infection.
Yes, experts suggest that chronic inflammation identified in long covid patients could be a therapeutic target for new treatments.
Long covid symptoms are diverse, including brain fog, fatigue, dizziness, gastrointestinal issues, and heart palpitations, lasting weeks to years.

Read more news on

Healthside-arrow

You may also like

Flu Season Low, But New Virus Strain Emerges

13 Dec • 27 reads

article image

Winter Illnesses Rise: Get Vaccinated!

12 Dec • 36 reads

article image

Holiday Flights: Avoid Germs on Planes

1 day ago • 11 reads

article image

Superflu Alert: US Faces Quadruple Virus Threat

10 Dec • 76 reads

article image

Winter Wellness: Beat Bugs This Season

4 Dec • 82 reads

article image